Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SRP + boric acid refers to the combination therapy of scaling and root planing (SRP), a standard non-surgical periodontal treatment, with adjunctive local application of boric acid. This combination is used in the management of periodontitis. Boric acid is applied either as a gel or via irrigation after mechanical debridement (SRP). The rationale for this approach is that while SRP removes dental plaque and calculus mechanically, the addition of boric acid provides antimicrobial effects—boric acid exhibits fungistatic and weak bacteriostatic properties, inhibits biofilm formation, hyphal transformation in fungi such as Candida albicans, and may reduce pathogenic bacteria associated with periodontitis[1][2][3][6]. Clinical studies have shown that adjunctive use of boric acid with SRP can lead to greater improvements in periodontal parameters such as probing pocket depth (PPD) reduction and clinical attachment level (CAL) gain compared to SRP alone or placebo[1][3]. The mechanism by which this occurs likely involves both direct antimicrobial action on subgingival pathogens and inhibition of biofilm formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SRP + boric acid.